Deferasirox

Common brands: Exjade, Jadenu, Deferasirox Oral Granules, Deferasorox, Folic Acid

Top reporter: Novartis Pharmaceuticals Corporation

Iron Chelator [EPC]Vitamin C [EPC]Vitamin B12 [EPC]Vitamin D [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]
26,252
Total Reports
10,186
Serious Reports
7,707
Death Reports
30
Reported Reactions
Death Report Ratio: High (29.36%)

Patient Demographics

Male
12,116
Female
11,722

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Deferasirox.

# Reaction Reports % of Total
1 DEATH 4,699
15.0%
2 DIARRHOEA 2,339
7.4%
3 SICKLE CELL ANAEMIA WITH CRISIS 1,807
5.7%
4 PYREXIA 1,463
4.7%
5 NAUSEA 1,426
4.5%
6 HAEMOGLOBIN DECREASED 1,406
4.5%
7 PNEUMONIA 1,247
4.0%
8 SERUM FERRITIN INCREASED 1,176
3.7%
9 MALAISE 1,129
3.6%
10 FATIGUE 1,121
3.6%
11 VOMITING 1,099
3.5%
12 ABDOMINAL PAIN 904
2.9%
13 PAIN 897
2.9%
14 BLOOD CREATININE INCREASED 830
2.6%
15 PLATELET COUNT DECREASED 819
2.6%
16 ANAEMIA 807
2.6%
17 ASTHENIA 801
2.5%
18 DYSPNOEA 784
2.5%
19 ABDOMINAL PAIN UPPER 672
2.1%
20 HEADACHE 655
2.1%
21 RASH 628
2.0%
22 WEIGHT DECREASED 564
1.8%
23 RENAL FAILURE 553
1.8%
24 SEPSIS 545
1.7%
25 DRUG INEFFECTIVE 543
1.7%
26 OFF LABEL USE 515
1.6%
27 INFECTION 509
1.6%
28 DIZZINESS 508
1.6%
29 ABDOMINAL DISCOMFORT 504
1.6%
30 DECREASED APPETITE 480
1.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.